Company / Operating Income
Phio Pharmaceuticals Corp. Operating Income History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$9.0M
FY2020
5-year range
-$14.1M / -$7.4M
FY2016-FY2020
Trend
-22.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 7 years, ranging from -$14M in FY2018 to -$7M in FY2019.
Based on SEC 10-K filings.
-$9M in FY2020.
Improved from -$14M to -$9M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, operating income decreased 22.0% year-over-year.
- Peak operating income was recorded in FY2019.
- Lowest operating income in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$9.0M | -22.0% |
| FY2019 | -$7.4M | +47.6% |
| FY2018 | -$14.1M | -56.0% |
| FY2017 | -$9.0M | +11.9% |
| FY2016 | -$10.2M | +21.1% |
| FY2013 | -$13.0M | -1.6% |
| FY2012 | -$12.8M | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026